Tysabri

New drugs often fail to match the hype
The News Journal - Wilmington,DE,USA
Members of a Food and Drug Administration advisory panel listen to a discussion on whether the MS drug Tysabri should be allowed to return to the market. ...

---

FTY720

Novartis Delivers Dynamic Sales and Earnings Growth in the First ...
PharmaLive.com (press release) - Newtown,PA,USA
... FTY720 (fingolimod), an oral once-daily treatment for relapsing-remitting multiple sclerosis (MS), has shown sustained benefits over two years in patients in ...